NIH Research Matters
December 15, 2014
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it.
Despite recommendations against the practice, many infants are still placed to sleep with bedding that increases the risk of suffocation and sudden infant death syndrome.
Researchers developed a drug that allows spinal cord neurons to grow after injury, improving movement and bladder function. The approach may lead to treatments for paralysis and other conditions.
December 8, 2014
Results from an international genomics effort will help scientists better understand how and when mouse models can best be used to study human biology and disease.
Experimental gene therapy improved symptoms for as long as 4 years in men with severe hemophilia. The study shows the potential for gene therapy to treat this and other disorders.
Researchers revealed how nucleotides damaged by oxidative stress block DNA repair mechanisms. The cell death triggered by this process is thought to play a role in many diseases.
November 24, 2014
Researchers identified mutations in 107 genes that may contribute to the risk for autism spectrum disorder. The findings may help lead to potential therapies.
An experimental drug showed promising results and potential problems in treating a common liver disease. The drugís long-term effects still need to be assessed.
By blocking mitochondria division, scientists were able to restore function in mouse models of Parkinsonís disease. These preliminary findings suggest a strategy to slow or halt the disease.
November 10, 2014
Computer model projections provide insight into the dynamics of the Ebola outbreak. Such models can help guide more effective control efforts.
While studying cognitive function in healthy adults, researchers discovered DNA from an algal virus in throat samples. The virus was associated with subtle cognitive changes.
The hearts of mice have resident macrophages, a type of immune cell, that play a key role in recovery from damage. The findings suggest novel treatment strategies for heart failure.
November 3, 2014
In some patients with suspected genetic conditions, a fast, powerful technique called whole-exome sequencing provided a molecular diagnosis.
Scientists illuminated the movement and complete structure of the spikes that the HIV virus uses to bind cells. The findings will help guide efforts to develop vaccines and treatments.
Researchers designed a cell culture system that reproduce key features of Alzheimer’s disease. The system may aid in drug development and the study of other neurodegenerative disorders.
October 20, 2014
Certain heart-related risk factors are present early in people diagnosed with schizophrenia spectrum disorders. The findings highlight early treatment opportunities.
An experimental vaccine against H7N9 avian influenza prompted substantial immune responses in 59% of volunteers. The approach could lead to improved flu vaccines.
Researchers transformed human stem cells into pancreatic beta cells that produce insulin and respond to glucose. The finding could lead to new therapies to treat diabetes.
NIH Research Matters
Bldg. 31, Rm. 5B64A, MSC 2094
Bethesda, MD 20892-2094
About NIH Research Matters
Editor: Harrison Wein, Ph.D.
Assistant Editors: Vicki Contie, Carol Torgan, Ph.D.
NIH Research Matters is a weekly update of NIH research highlights from the Office of Communications and Public Liaison, Office of the Director, National Institutes of Health.